Modelling KIR-HLA genotype disparities in type 1 diabetes

Tissue Antigens

Volumn 69, Issue SUPPL. 1, 2007, Pages 101-105

  Van Der Slik, A R ^a   Alizadeh, B Z ^b   Koeleman, B P C ^a,b   Roep, B O ^a   Giphart, M J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autoimmune disease; Genetic risk; HLA ligands; Killer cell immunoglobulin like receptors

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE ANTIGEN;

AUTOIMMUNITY; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HLA SYSTEM; HUMAN; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTECTION;

ADOLESCENT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; GENOTYPE; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MODELS, BIOLOGICAL; RECEPTORS, IMMUNOLOGIC;

EID: 34247208744     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.762_5.x     Document Type: Conference Paper

References (12)

1. Roep BO. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia 2003: 46: 305-21.
2. Uhrberg M, Valiante NM, Young NT, Lanier LL, Philips JH, Parham P. The repertoire of Killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical αβ TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J Immunol 2001: 166: 3923-32.
3. van Bergen J, Thompson A, van der Slik A, Ottenhoff THM, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 2004: 173: 6719-26.
4. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptors genes. Immunity 1997: 7: 753-63.
5. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 2004: 173: 4273-6.
6. Williams F, Meenagh A, Sleator C et al. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 2005: 66: 836-41.
7. van der Slik AR, Koeleman BPC, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003: 52: 2639-42.
8. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998: 161: 571-7.
9. Khakoo SI, Thio CL, Martin MP et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004: 305: 872-4.
10. Hiby SE, Walker JJ, O'Shaughnessy KM et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004: 200: 957-65.
11. Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 2005: 175: 5222-9.
12. Schipper RF, Koeleman BPC, Bruining GJ et al. HLA class II associations with type 1 diabetes mellitus: a multivariate approach. Tissue Antigens 2001: 57: 144-50.